Literature DB >> 31509182

Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson's tremor.

Michiel F Dirkx1,2, Heidemarie Zach1,2,3, Annelies van Nuland1, Bastiaan R Bloem2, Ivan Toni1, Rick C Helmich1,2.   

Abstract

Rest tremor in Parkinson's disease is related to cerebral activity in both the basal ganglia and a cerebello-thalamo-cortical circuit. Clinically, there is strong interindividual variation in the therapeutic response of tremor to dopaminergic medication. This observation casts doubt on the idea that Parkinson's tremor has a dopaminergic basis. An interesting alternative explanation is that interindividual differences in the pathophysiology of tremor may underlie this clinical heterogeneity. Previous work showed that dopaminergic medication reduces Parkinson's tremor by inhibiting tremulous activity in the pallidum and thalamus, and this may explain why some tremors are dopamine-responsive. Here we test the hypothesis that dopamine-resistant resting tremor may be explained by increased contributions of non-dopaminergic brain regions, such as the cerebellum. To test this hypothesis, we first performed a levodopa challenge test in 83 tremulous Parkinson's disease patients, and selected 20 patients with a markedly dopamine-responsive tremor (71% reduction) and 14 patients with a markedly dopamine-resistant tremor (6% reduction). The dopamine response of other core motor symptoms was matched between groups. Next, in all 34 patients, we used combined EMG-functional MRI to quantify tremor-related brain activity during two separate sessions (crossover, double-blind, counterbalanced design): after placebo, or after 200/50 mg dispersible levodopa/benserazide. We compared tremor-related brain activity between groups and medication sessions. Both groups showed tremor amplitude-related brain activity in a cerebello-thalamo-cortical circuit. Dopamine-resistant tremor patients showed increased tremor-related activity in non-dopaminergic areas (cerebellum), whereas the dopamine-responsive group showed increased tremor-related activity in the thalamus and secondary somatosensory cortex (across medication sessions). Levodopa inhibited tremor-related thalamic responses in both groups, but this effect was significantly greater in dopamine-responsive patients. These results suggest that dopamine-resistant tremor may be explained by increased cerebellar and reduced somatosensory influences onto the cerebellar thalamus, making this region less susceptible to the inhibitory effects of dopamine.
© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Parkinson’s disease; epidemiology; imaging; neurophysiology; tremor

Mesh:

Substances:

Year:  2019        PMID: 31509182     DOI: 10.1093/brain/awz261

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  14 in total

1.  Different iron deposition patterns in Parkinson's disease subtypes: a quantitative susceptibility mapping study.

Authors:  Junling Chen; Tongtong Cai; Yan Li; Jieshan Chi; Siming Rong; Chentao He; Xiaohong Li; Piao Zhang; Lijuan Wang; Yuhu Zhang
Journal:  Quant Imaging Med Surg       Date:  2020-11

Review 2.  A review on pathology, mechanism, and therapy for cerebellum and tremor in Parkinson's disease.

Authors:  Yuke Zhong; Hang Liu; Guohui Liu; Lili Zhao; Chengcheng Dai; Yi Liang; Juncong Du; Xuan Zhou; Lijuan Mo; Changhong Tan; Xinjie Tan; Fen Deng; Xi Liu; Lifen Chen
Journal:  NPJ Parkinsons Dis       Date:  2022-06-24

3.  Subthalamic-Cortical Network Reorganization during Parkinson's Tremor.

Authors:  Peter M Lauro; Shane Lee; Umer Akbar; Wael F Asaad
Journal:  J Neurosci       Date:  2021-10-26       Impact factor: 6.709

4.  Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Prabesh Kanel; Robert A Koeppe; Carlos A Sanchez-Catasus; Kirk A Frey; Peter Scott; Gregory M Constantine; Roger L Albin; Martijn L T M Müller
Journal:  Brain Commun       Date:  2021-05-22

5.  Mapping dopaminergic projections in the human brain with resting-state fMRI.

Authors:  Koen V Haak; Christian F Beckmann; Marianne Oldehinkel; Alberto Llera; Myrthe Faber; Ismael Huertas; Jan K Buitelaar; Bastiaan R Bloem; Andre F Marquand; Rick C Helmich
Journal:  Elife       Date:  2022-02-03       Impact factor: 8.140

Review 6.  The Role of the Cerebellum in Tremor - Evidence from Neuroimaging.

Authors:  Kevin R E van den Berg; Rick C Helmich
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-11-15

7.  Cholinergic relevant functional reactivity is associated with dopamine responsiveness of tremor in Parkinson's disease.

Authors:  Jingjing Wu; Cheng Zhou; Tao Guo; Xiaojun Guan; Ting Gao; Xueqin Bai; Haoting Wu; Jingwen Chen; Jiaqi Wen; Xiaocao Liu; Luyan Gu; Zhe Song; Min Xuan; Quanquan Gu; Peiyu Huang; Jiali Pu; Baorong Zhang; Xiaojun Xu; Minming Zhang
Journal:  Brain Imaging Behav       Date:  2022-01-01       Impact factor: 3.224

8.  Clinical and Kinematic Features of Valproate-Induced Tremor and Differences with Essential Tremor.

Authors:  Giulia Paparella; Luca Angelini; Alessandro De Biase; Antonio Cannavacciuolo; Donato Colella; Carlo Di Bonaventura; Anna Teresa Giallonardo; Alfredo Berardelli; Matteo Bologna
Journal:  Cerebellum       Date:  2020-11-16       Impact factor: 3.847

9.  Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype.

Authors:  Annelies J van Nuland; Rick C Helmich; Michiel F Dirkx; Heidemarie Zach; Ivan Toni; Roshan Cools; Hanneke E M den Ouden
Journal:  Brain       Date:  2020-12-05       Impact factor: 15.255

10.  Locus Coeruleus Degeneration Correlated with Levodopa Resistance in Parkinson's Disease: A Retrospective Analysis.

Authors:  Cheng Zhou; Tao Guo; JingJing Wu; Linbo Wang; Xueqin Bai; Ting Gao; Xiaojun Guan; Luyan Gu; Peiyu Huang; Min Xuan; Quanquan Gu; Xiaojun Xu; Baorong Zhang; Wei Cheng; Jianfeng Feng; Minming Zhang
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.